San Rafael, United States
Koniku, founded in 2015 and headquartered in the United States, is pioneering the integration of biological neurons into technology, trademarked by their bold maxim, "Bio is Tech™."
The company is a trailblazer in the domains of Biotechnology, Health and Wellness, IoT, Life Sciences, and Machine Learning. By treating neurons as intelligent materials, Koniku is pushing boundaries in neurotechnology and is the first of its kind to develop products that bridge biology with advanced devices, including brain-machine interfaces and living devices.
Backed by a robust $37.00M Series A investment secured on December 17, 2021, Koniku counts heavyweights like Airbus Ventures, IDO Investments, Presight Capital, SoftBank Vision Fund, and Platform Capital among its investors. This financing reflects the substantial confidence in their unique technological approach, suggesting a poised trajectory for substantial growth and innovation.
